129 related articles for article (PubMed ID: 15941597)
1. Modification of a viral envelope glycoprotein cell-cell fusion assay by utilizing plasmid encoded bacteriophage RNA polymerase.
Lin G; Murphy SL; Gaulton GN; Hoxie JA
J Virol Methods; 2005 Sep; 128(1-2):135-42. PubMed ID: 15941597
[TBL] [Abstract][Full Text] [Related]
2. Use of GPR1, GPR15, and STRL33 as coreceptors by diverse human immunodeficiency virus type 1 and simian immunodeficiency virus envelope proteins.
Edinger AL; Hoffman TL; Sharron M; Lee B; O'Dowd B; Doms RW
Virology; 1998 Sep; 249(2):367-78. PubMed ID: 9791028
[TBL] [Abstract][Full Text] [Related]
3. Host range of human T-cell leukemia virus type I analyzed by a cell fusion-dependent reporter gene activation assay.
Okuma K; Nakamura M; Nakano S; Niho Y; Matsuura Y
Virology; 1999 Feb; 254(2):235-44. PubMed ID: 9986790
[TBL] [Abstract][Full Text] [Related]
4. The role of cholesterol and sphingolipids in chemokine receptor function and HIV-1 envelope glycoprotein-mediated fusion.
Ablan S; Rawat SS; Viard M; Wang JM; Puri A; Blumenthal R
Virol J; 2006 Dec; 3():104. PubMed ID: 17187670
[TBL] [Abstract][Full Text] [Related]
5. Truncation of the human immunodeficiency virus-type-2 envelope glycoprotein allows efficient pseudotyping of murine leukemia virus retroviral vector particles.
Höhne M; Thaler S; Dudda JC; Groner B; Schnierle BS
Virology; 1999 Aug; 261(1):70-8. PubMed ID: 10441556
[TBL] [Abstract][Full Text] [Related]
6. Functional expression of CD4, CXCR4, and CCR5 in glycosphingolipid-deficient mouse melanoma GM95 cells and susceptibility to HIV-1 envelope glycoprotein-triggered membrane fusion.
Rawat SS; Eaton J; Gallo SA; Martin TD; Ablan S; Ratnayake S; Viard M; KewalRamani VN; Wang JM; Blumenthal R; Puri A
Virology; 2004 Jan; 318(1):55-65. PubMed ID: 14972535
[TBL] [Abstract][Full Text] [Related]
7. A macrophage fusion assay for rapid screening of cloned HIV-1 Env using dual recombinant vaccinia viruses expressing distinct RNA polymerases.
Isaacs SN; Yi Y; Singh A; Collman RG
J Virol Methods; 1999 Aug; 81(1-2):55-61. PubMed ID: 10488761
[TBL] [Abstract][Full Text] [Related]
8. Inter-retroviral fusion mediated by human immunodeficiency virus or murine leukemia virus glycoproteins: independence of cellular membranes and membrane vesicles.
Sparacio S; Pfeiffer T; Holtkotte D; Bosch V
Virology; 2002 Mar; 294(2):305-11. PubMed ID: 12009872
[TBL] [Abstract][Full Text] [Related]
9. Activation of membrane fusion by murine leukemia viruses is controlled in cis or in trans by interactions between the receptor-binding domain and a conserved disulfide loop of the carboxy terminus of the surface glycoprotein.
Lavillette D; Boson B; Russell SJ; Cosset FL
J Virol; 2001 Apr; 75(8):3685-95. PubMed ID: 11264358
[TBL] [Abstract][Full Text] [Related]
10. Elevated expression of GM3 in receptor-bearing targets confers resistance to human immunodeficiency virus type 1 fusion.
Rawat SS; Gallo SA; Eaton J; Martin TD; Ablan S; KewalRamani VN; Wang JM; Blumenthal R; Puri A
J Virol; 2004 Jul; 78(14):7360-8. PubMed ID: 15220409
[TBL] [Abstract][Full Text] [Related]
11. An essential role for the His-8 residue of the SDF-1alpha-chimeric, tropism-redirected Env protein of the Moloney murine leukemia virus in regulating postbinding fusion events.
Katane M; Fujita R; Takao E; Kubo Y; Aoki Y; Amanuma H
J Gene Med; 2004 Mar; 6(3):260-7. PubMed ID: 15026987
[TBL] [Abstract][Full Text] [Related]
12. Membrane fusion between retroviral particles: host-range extension and vaccine prospects.
Sparacio S; Zeilfelder U; Pfeiffer T; Henzler T; Bosch V
Virology; 2000 Jun; 271(2):248-52. PubMed ID: 10860878
[TBL] [Abstract][Full Text] [Related]
13. Actin cytoskeletal reorganizations and coreceptor-mediated activation of rac during human immunodeficiency virus-induced cell fusion.
Pontow SE; Heyden NV; Wei S; Ratner L
J Virol; 2004 Jul; 78(13):7138-47. PubMed ID: 15194790
[TBL] [Abstract][Full Text] [Related]
14. Use of dual recombinant vaccinia virus vectors to assay viral glycoprotein-mediated fusion with transfection-resistant primary cell targets.
Yi Y; Singh A; Cutilli J; Collman RG
Methods Mol Biol; 2004; 269():333-46. PubMed ID: 15114024
[TBL] [Abstract][Full Text] [Related]
15. Selective elimination of HIV-1-infected cells by Env-directed, HIV-1-based virus-like particles.
Peretti S; Schiavoni I; Pugliese K; Federico M
Virology; 2006 Feb; 345(1):115-26. PubMed ID: 16271741
[TBL] [Abstract][Full Text] [Related]
16. Specific interaction of CXCR4 with CD4 and CD8alpha: functional analysis of the CD4/CXCR4 interaction in the context of HIV-1 envelope glycoprotein-mediated membrane fusion.
Basmaciogullari S; Pacheco B; Bour S; Sodroski J
Virology; 2006 Sep; 353(1):52-67. PubMed ID: 16808956
[TBL] [Abstract][Full Text] [Related]
17. Chemokine (C-C motif) receptor 5-using envelopes predominate in dual/mixed-tropic HIV from the plasma of drug-naive individuals.
Irlbeck DM; Amrine-Madsen H; Kitrinos KM; Labranche CC; Demarest JF
AIDS; 2008 Jul; 22(12):1425-31. PubMed ID: 18614865
[TBL] [Abstract][Full Text] [Related]
18. Cytopathic effect determined by the amount of CD4 molecules in human cell lines expressing envelope glycoprotein of HIV.
Koga Y; Sasaki M; Yoshida H; Wigzell H; Kimura G; Nomoto K
J Immunol; 1990 Jan; 144(1):94-102. PubMed ID: 2404066
[TBL] [Abstract][Full Text] [Related]
19. Selective gene transfer to T lymphocytes using coreceptor-specific [MLV(HIV)] pseudotype vectors in a transgenic mouse model.
Schüle S; Steidl S; Panitz S; Coulibaly C; Kalinke U; Cichutek K; Schweizer M
Virology; 2006 Jul; 351(1):237-47. PubMed ID: 16650881
[TBL] [Abstract][Full Text] [Related]
20. A sensitive HIV-1 envelope induced fusion assay identifies fusion enhancement of thrombin.
Cheng DC; Zhong GC; Su JX; Liu YH; Li Y; Wang JY; Hattori T; Ling H; Zhang FM
Biochem Biophys Res Commun; 2010 Jan; 391(4):1780-4. PubMed ID: 20045672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
